High Note Wealth’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.12K Buy
21
+14
+200% +$5.19K ﹤0.01% 456
2026
Q1
$2.05K Sell
7
-12
-63% -$3.94K ﹤0.01% 779
2025
Q4
$6.66K Sell
19
-10
-34% -$3.38K ﹤0.01% 415
2025
Q3
$9.37K Sell
29
-6
-17% -$1.87K ﹤0.01% 323
2025
Q2
$13.6K Buy
35
+2
+6% +$804 ﹤0.01% 274
2025
Q1
$14.4K Buy
33
+14
+74% +$5.62K ﹤0.01% 258
2024
Q4
$7.01K Buy
+19
New +$7.95K ﹤0.01% 347

Other funds holding ELV

High Note Wealth's ELV Position: Q2 2026 in Review

High Note Wealth increased its Elevance Health (ELV) stake by 200% in Q2 2026, buying an estimated $5.19K and bringing the position to 21 shares worth $8.12K. The position accounts for ﹤0.01% of the portfolio, ranked #456.

High Note Wealth first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. The position peaked at $14.4K in Q1 2025. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • High Note Wealth held 21 shares of Elevance Health worth $8.12K as of Q2 2026.
  • High Note Wealth bought 14 Elevance Health shares in Q2 2026, an estimated $5.19K.
  • Elevance Health made up ﹤0.01% of High Note Wealth's portfolio in Q2 2026, its #456 holding.
  • High Note Wealth first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • High Note Wealth's Elevance Health position peaked at $14.4K in Q1 2025.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on High Note Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.